DEA Reschedules Cannabis to Schedule III in Historic Decision
DEA cannabis rescheduling In a groundbreaking move, the Drug Enforcement Administration (DEA) has agreed to reschedule cannabis to Schedule III, a significant shift in federal drug policy. This decision acknowledges the medical benefits of cannabis, aligning with recommendations from health officials who have long advocated for its therapeutic potential. The change marks a departure from … Read more